Global University Venturing

Oxford Brain Diagnostics hopes to commercialise an early diagnosis tool for Alzheimer’s disease pioneered through eight years of University of Oxford research.

Cell culturing technology Cellink has bought University of Freiburg's single-cell dispensing spinout Cytena for almost $34m.

Motion-to-compel fines have been served to parties from Stanford University and Stanford-StartX Fund for blocking MedWhat's discovery request in the ongoing legal case.

Mission Bay Capital has backed a series B round for orphan diseases drug developer Glycomine, which also attracted Novo, Asahi Kasei Pharma and Chiesi.

BlueDot, a disease containment technology spinout set up by St Michael’s Hospital and Mars Innovation, has secured series A capital.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

HKU has selected 25 university-linked businesses to receive funding from its portion of the government-funded Technology Start-up Support Scheme for Universities.

Allied Minds has returned again for a series B round that took the firm's geospatial data analytics technology subsidiary's total funding to about $96m.

UVC Partners has backed a $13.5m round that came four years after the diagnostic technology spinout of LMU secured a series B featuring UnternehmerTUM.

OUP, Celgene and Astellas Venture Management all supplied a portion of the funding to bring the Caltech-founded cancer drug developer's lifetime funding to $92m.

Mobility analytics provider Teralytics, an ETH Zurich spinout, has added funding from investors including Robert Bosch Venture Capital and Atomico.